PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Vulnerable brain region may be central to progression of Alzheimer's disease

2010-11-04
(Press-News.org) New research is helping to unravel the events that underlie the "spread" of Alzheimer's disease (AD) throughout the brain. The research, published by Cell Press in the November 4th issue of the journal Neuron, follows disease progression from a vulnerable brain region that is affected early in the disease to interconnected brain regions that are affected in later stages. The findings may contribute to design of therapeutic interventions as targeting the brain region where AD originates would be simpler than targeting multiple brain areas.

An alteration in brain levels of amyloid ?-proteins (A?) plays a major pathogenic role in AD, a devastating neurodegenerative disorder that causes progressive cognitive impairment and memory loss. AD is characterized by abnormal accumulation of A? in the brain, which leads to the formation of protein aggregates that are toxic to neurons. A? peptides are generated when a large protein called amyloid precursor protein (APP) is cut up into smaller pieces.

One of the first brain regions affected in AD is the entorhinal cortex (EC). Communication between the EC and the hippocampus is critical for memory and disruption of this circuit may play a role in memory impairment in the beginning stages of AD. "It is not clear how EC dysfunction contributes to cognitive decline in AD or whether early vulnerability of the EC initiates the spread of dysfunction through interconnected neural networks," explains senior study author, Dr. Lennart Mucke from the Gladstone Institutes and the University of California, San Francisco. "To address these questions, we studied transgenic mice with spatially restricted overexpression of mutant APP primarily in neurons of the EC."

Dr. Mucke and colleagues found that overexpression of mutant APP/ A? selectively in the EC led to age-dependent deficits in learning and memory along with other behavioral deficits, including hyperactivity and disinhibition. Importantly, these abnormalities are similar to those observed in mouse models of AD with mutant APP expression throughout the brain. The researchers also observed abnormalities in the hippocampus, including dysfunction of synapses and A??deposits in part of the hippocampus that receive input from the EC.

"Our findings directly support the hypothesis that AD-related dysfunction is propagated through networks of neurons, with the EC as an important hub region of early vulnerability," concludes Dr. Mucke. "Although additional studies are needed to better understand how events in the EC are related to AD, it is conceivable that early interference in the EC might be of therapeutic benefit, perhaps halting disease progression."

###

END



ELSE PRESS RELEASES FROM THIS DATE:

Plasticity supports cognitive recovery after brain damage

2010-11-04
New research provides fascinating insight into mechanisms that underlie recovery after damage to a region of the brain important for memory and attention. The research, published by Cell Press in the November 4th issue of the journal Neuron, highlights the role of undamaged portions of the brain that can "take over" and support the recovery of function. Brain damage can have devastating consequences, depending on the location and severity of the injury. Damage to an area of the brain called the prefrontal cortex often results in deficits in memory and attention. However, ...

Armed antibody triggers remissions for Hodgkin's lymphoma

2010-11-04
HOUSTON ― An antibody loaded with an anti-cancer agent produced complete or partial remissions in 38 percent of patients with relapsed or therapy-resistant Hodgkin lymphoma enrolled in a phase I clinical trial, investigators report in the Nov. 4 issue of the New England Journal of Medicine. "That level of objective responses to a drug is impressive for a Phase I trial," said study lead author Anas Younes, M.D., professor in The University of Texas MD Anderson Cancer Center's Department of Lymphoma/Myeloma. "These encouraging results are being confirmed in a large ...

Combining radiation therapy, chemotherapy safely treats head and neck cancer patients

2010-11-04
SAN DIEGO, Nov. 3 – Stereotactic body radiotherapy (SBRT), a radiation therapy procedure pioneered at the University of Pittsburgh Cancer Institute (UPCI) that precisely delivers a large dose of radiation to tumors, may effectively control and treat head and neck cancers when combined with the chemotherapy Cetuximab, according to researchers from UPCI. The results of the research will be presented today at the American Society for Radiation Oncology (ASTRO) annual meeting in San Diego. The study, led by Dwight E. Heron, M.D., professor of otolaryngology and vice chairman ...

Higher medication spending doesn't indicate better prescribing quality

2010-11-04
PITTSBURGH, Nov. 3 – Medicare patients in regions that spend the most on prescription medications are not necessarily getting better quality care, according to a new study of spending practices from the University of Pittsburgh Graduate School of Public Health (GSPH). The findings, published in the Nov. 3 Online First issue of the New England Journal of Medicine, reveal great variation across the country in both drug spending and the rate of inappropriate prescriptions for the elderly. Lead investigator Yuting Zhang, Ph.D., assistant professor of health economics at GSPH, ...

Study shows drop in unnecessary care after Medicare reimbursement cut

2010-11-04
ANN ARBOR, Mich. — When Medicare policy changes led to reductions in reimbursement for hormonal treatment of prostate cancer, there was a sharp decline in its use among patients not likely to benefit from the treatment. But among patients for whom the therapy is clearly beneficial, doctors continued to prescribe it at the same rate, according to a new study. This finding suggests that financial reform of health care can reduce unnecessary care without impacting care to those patients most likely to benefit from a treatment. "We found that physicians respond to reimbursement, ...

Meta-flex: Your new brand for invisibility clothing

2010-11-04
Flexible smart materials that can manipulate light to shield objects from view have been much-theorised but now researchers in Scotland have made a practical breakthrough that brings the possibility of an invisibility cardigan – or any other item of invisibility clothing - one step closer. Two challenges to the creation of smart flexible materials that can cloak from visible light are making meta-atoms small enough to interact with visible light, and the fabrication of metamaterials that can be detached from the hard surfaces they are developed on to be used in more ...

Recombination hotspot stacks the DNA deck in finding a new diabetes susceptibility gene

2010-11-04
November 4, 2010 – The autoimmune disease type 1 diabetes (T1D), also known as juvenile diabetes, is diagnosed in approximately 70,000 children worldwide per year. Genetics is increasingly being recognized as playing a significant role in susceptibility to the disorder, but outside a handful of genes, a clear understanding of the genetic architecture that underlies T1D has remained elusive. In a study published online today in Genome Research (www.genome.org), scientists have identified a novel gene associated with diabetes in mice that is revealing new clues about genomic ...

New compounds may treat both alcohol and cigarette addictions

2010-11-04
Researchers at the Ernest Gallo Clinic and Research Center at the University of California, San Francisco, and Pfizer Inc., have determined that two new compounds may be effective in treating both alcohol and nicotine dependence at the same time. In a paper published in the November 3, 2010 issue of Neuropsychopharmacology, the researchers showed that alcohol consumption in rodents was significantly decreased by two compounds that target neuronal nicotinic acetylcholine receptor (nAChR) subtype 34*. nAChRs are proteins found in the brain and broader ...

Moving holograms: From science fiction to reality

Moving holograms: From science fiction to reality
2010-11-04
Remember the Star Wars scene in which R2D2 projects a three-dimensional image of a troubled Princess Leia delivering a call for help to Luke Skywalker and his allies? What used to be science fiction is now close to becoming reality thanks to a breakthrough in 3D holographic imaging technology developed at the University of Arizona College of Optical Sciences. A team led by optical sciences professor Nasser Peyghambarian developed a new type of holographic telepresence that allows the projection of a three-dimensional, moving image without the need for special eyewear ...

Gladstone scientists identify process by which Alzheimer's disease creeps through the brain

2010-11-04
SAN FRANCISCO, CA – November 3, 2010—Scientists at the Gladstone Institute of Neurological Disease (GIND) have offered new information about the events that underlie the "spread" of Alzheimer's disease (AD) throughout the brain. The research, published in the November 4th issue of the journal Neuron, follows disease progression from a vulnerable brain region that is affected early in the disease to interconnected brain regions that are affected in later stages. The findings may contribute to design of therapeutic interventions, as targeting the brain region where AD originates ...

LAST 30 PRESS RELEASES:

Early relapse predicts poor outcomes in aggressive blood cancer

American College of Lifestyle Medicine applauds two CMS models aligned with lifestyle medicine practice and reimbursement

Clinical trial finds cannabis use not a barrier to quitting nicotine vaping

Supplemental nutrition assistance program policies and food insecurity

Switching immune cells to “night mode” could limit damage after a heart attack, study suggests

URI-based Global RIghts Project report spotlights continued troubling trends in worldwide inhumane treatment

Neutrophils are less aggressive at night, explaining why nighttime heart attacks cause less damage than daytime events

Menopausal hormone therapy may not pose breast cancer risk for women with BRCA mutations

Mobile health tool may improve quality of life for adolescent and young adult breast cancer survivors

Acupuncture may help improve perceived breast cancer-related cognitive difficulties over usual care

Nerve block may reduce opioid use in infants undergoing cleft palate surgery

CRISPR primes goldenberry for fruit bowl fame

Mass General Brigham announces new AI company to accelerate clinical trial screening and patient recruitment

Fat tissue around the heart may contribute to greater heart injury after a heart attack

Jeonbuk National University researcher proposes a proposing a two-stage decision-making framework of lithium governance in Latin America

Chromatin accessibility maps reveal how stem cells drive myelodysplastic progression

Cartilaginous cells regulate growth and blood vessel formation in bones

Plant hormone allows lifelong control of proteins in living animal for first time

Swedish freshwater bacteria give new insights into bacterial evolution

Global measures consistently underestimate food insecurity; one in five who suffer from hunger may go uncounted

Hidden patterns of isolation and segregation found in all American cities

FDA drug trials exclude a widening slice of Americans

Sea reptile’s tooth shows that mosasaurs could live in freshwater

Pure bred: New stem cell medium only has canine components

Largest study of its kind highlights benefits – and risks – of plant-based diets in children

Synergistic effects of single-crystal HfB2 nanorods: Simultaneous enhancement of mechanical properties and ablation resistance

Mysterious X-ray variability of the strongly magnetized neutron star NGC 7793 P13

The key to increasing patients’ advance care medical planning may be automatic patient outreach

Palaeontology: Ancient tooth suggests ocean predator could hunt in rivers

Polar bears may be adapting to survive warmer climates, says study

[Press-News.org] Vulnerable brain region may be central to progression of Alzheimer's disease